ES2074131T4 - Acidos azabicicloquinolonacarboxilicos. - Google Patents

Acidos azabicicloquinolonacarboxilicos.

Info

Publication number
ES2074131T4
ES2074131T4 ES90308331T ES90308331T ES2074131T4 ES 2074131 T4 ES2074131 T4 ES 2074131T4 ES 90308331 T ES90308331 T ES 90308331T ES 90308331 T ES90308331 T ES 90308331T ES 2074131 T4 ES2074131 T4 ES 2074131T4
Authority
ES
Spain
Prior art keywords
acids
azabicicloquinolonacarboxilic
azabiciclo
quinolone
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90308331T
Other languages
English (en)
Other versions
ES2074131T3 (es
Inventor
Katherine Elizabeth Brighty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Corp Belgium
Pfizer Corp SRL
Original Assignee
Pfizer Corp Belgium
Pfizer Corp SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Corp Belgium, Pfizer Corp SRL filed Critical Pfizer Corp Belgium
Publication of ES2074131T3 publication Critical patent/ES2074131T3/es
Application granted granted Critical
Publication of ES2074131T4 publication Critical patent/ES2074131T4/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

ACIDOS QUINOLONA CARBOXILICOS 7-SUSTITUIDOS POR GRUPOS AZABICICLO TIENEN ACTIVIDAD ANTIBACTERIANA.
ES90308331T 1989-08-16 1990-07-30 Acidos azabicicloquinolonacarboxilicos. Expired - Lifetime ES2074131T4 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/003489 WO1991002526A1 (en) 1989-08-16 1989-08-16 Azabicyclo quinolone carboxylic acids

Publications (2)

Publication Number Publication Date
ES2074131T3 ES2074131T3 (es) 1995-09-01
ES2074131T4 true ES2074131T4 (es) 1996-05-01

Family

ID=22215165

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90308331T Expired - Lifetime ES2074131T4 (es) 1989-08-16 1990-07-30 Acidos azabicicloquinolonacarboxilicos.

Country Status (30)

Country Link
EP (1) EP0413455B1 (es)
JP (2) JPH072734B2 (es)
KR (1) KR930004844B1 (es)
CN (1) CN1025192C (es)
AT (1) ATE124040T1 (es)
AU (1) AU623801B2 (es)
BA (1) BA98299A (es)
CA (2) CA2127561C (es)
CY (2) CY1969A (es)
CZ (1) CZ281127B6 (es)
DD (1) DD298399A5 (es)
DE (3) DE69020262T2 (es)
DK (1) DK0413455T3 (es)
EG (1) EG19251A (es)
ES (1) ES2074131T4 (es)
FI (2) FI108228B (es)
GR (1) GR3017072T3 (es)
HK (1) HK1000207A1 (es)
HU (2) HU219403B (es)
IE (1) IE66202B1 (es)
IL (1) IL95331A (es)
LU (2) LU90310I2 (es)
NL (2) NL980032I2 (es)
NO (1) NO300214B1 (es)
NZ (1) NZ234920A (es)
PL (1) PL166381B1 (es)
PT (1) PT94998B (es)
RU (1) RU2049777C1 (es)
WO (1) WO1991002526A1 (es)
ZA (1) ZA906450B (es)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0449445A3 (en) * 1990-03-27 1993-08-25 Pfizer Inc. Preparation of beta-ketoesters useful in preparing quinolone antibiotics
FR2675144B1 (fr) * 1991-04-10 1995-06-16 Bouchara Sa Nouvelles quinolones difluorees - leur procede de preparation et les compositions pharmaceutiques en renfermant.
DE69230005T2 (de) * 1991-06-19 2000-01-05 Pfizer Inc., New York Azaspirochinolone als antibakterielle Wirkstoffe
US5256791A (en) * 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
US5527910A (en) * 1992-12-30 1996-06-18 Cheil Foods & Chemicals, Inc. Pyridone carboxylic acid compounds and their uses for treating infectious diseases caused by bacteria
US5591766A (en) * 1993-12-03 1997-01-07 Cheil Foods & Chemicals, Inc. Solid oral formulations of pyridone carboxylic acids
AU699636B2 (en) * 1994-02-04 1998-12-10 Dainippon Pharmaceutical Co. Ltd. Bicyclic amino group-substituted pyridonecarboxylic acid derivatives, esters thereof and salts thereof, and bicyclic amines useful as intermediates thereof
DE69627985T2 (de) * 1995-02-02 2004-02-19 Daiichi Pharmaceutical Co., Ltd. Heterozyklische verbindungen
JPH08213881A (ja) * 1995-02-02 1996-08-20 Fujitsu Ltd 周波数制御回路
EA003334B1 (ru) * 1995-02-07 2003-04-24 Дайити Фармасьютикал Ко., Лтд. Производные пиридонкарбоновой кислоты и антибактериальная композиция на их основе
WO1996039406A1 (en) * 1995-06-06 1996-12-12 Pfizer Inc. NOVEL CRYSTAL FORM OF ANHYDROUS 7-([1α, 5α, 6α]-6-AMINO-3-AZABICYCLO[3.1.0]HEX-3-YL)-6-FLUORO-1-(2,4-DIFLUOROPHENYL)-1,4-DIHYDRO-4-OXO-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID, METHANESULFONIC ACID SALT
US5939550A (en) * 1995-06-15 1999-08-17 Pfizer Inc. Process for preparing derivatives of azabicyclo naphthyridine carboxylic acid comprising a dipeptide
AU711914B2 (en) * 1996-02-09 1999-10-21 Toyama Chemical Co. Ltd. Quinolonecarboxylic acid derivatives or their salts
AP788A (en) * 1996-08-26 1999-12-03 Pfizer Novel crystal form of anhydrous 7-(1a, 5a, 6a)-6-Amino-3-Azabicyclo(3.1.0) hex-3-YI)-6-Fluoro-1-(2,4- Difluorophenyl)-1,4-Dihydro-4-Oxo-1, 8-Naphthyridine-3-Carboxylic Acid, Methanesulfonic acid salt.
TW519542B (en) * 1996-09-27 2003-02-01 Daiichi Seiyaku Co Bicyclic amine derivative
DE69729213T2 (de) * 1996-10-25 2005-05-04 Daiichi Pharmaceutical Co., Ltd. Tricyclische aminderivate
US20020032216A1 (en) 1997-03-21 2002-03-14 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
MA24500A1 (fr) 1997-03-21 1998-10-01 Lg Life Sciences Ltd Derive du sel d'acide carboxylique de naphthyridine .
DE19733439A1 (de) * 1997-08-02 1999-02-04 Bayer Ag Neue 6-endo-Amino-3-azabicyclo(3.1.0)hexande, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Chinolon- und Naphthyridincarbonsäure-Derviaten mit verbesserten Eigenschaften
PE128799A1 (es) 1997-09-15 2000-02-17 Procter & Gamble Quinolinas antimicrobianas y sus composiciones
PA8464701A1 (es) * 1998-01-16 2000-09-29 Pfizer Prod Inc Procedimiento e intermedios para preparar naftiridonas
US6184380B1 (en) * 1999-01-25 2001-02-06 Pfizer Inc. Process for preparing naphthyridones and intermediates
US7019142B2 (en) 1998-01-16 2006-03-28 Pfizer Inc. Process for preparing naphthyridones and intermediates
GB9820405D0 (en) * 1998-09-18 1998-11-11 Smithkline Beecham Plc Process
EP2275141A1 (en) 1999-03-17 2011-01-19 Daiichi Pharmaceutical Co., Ltd. Tastemasked pharmaceutical compositions
GB9920917D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel process
GB9920919D0 (en) 1999-09-03 1999-11-10 Sb Pharmco Inc Novel compound
AU3089102A (en) 2000-12-14 2002-06-24 Procter & Gamble Antimicrobial quinolones
WO2002048143A2 (en) 2000-12-14 2002-06-20 The Procter & Gamble Company Antimicrobial 2-pyridones, their compositions and uses
KR100517638B1 (ko) 2002-04-08 2005-09-28 주식회사 엘지생명과학 게미플록사신 산염의 새로운 제조방법
AU2002345266B2 (en) 2002-07-08 2009-07-02 Ranbaxy Laboratories Limited 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists
CN1688544A (zh) 2002-08-23 2005-10-26 兰贝克赛实验室有限公司 作为蕈毒碱受体拮抗剂的含氟代和磺酰氨基的3,6－二取代的氮杂双环(3.1.0)己烷衍生物
WO2004089898A1 (en) 2003-04-09 2004-10-21 Ranbaxy Laboratories Limited Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
EP1615634B1 (en) 2003-04-10 2007-05-16 Ranbaxy Laboratories, Ltd. Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
CN100436414C (zh) 2003-04-11 2008-11-26 兰贝克赛实验室有限公司 作为毒蕈碱受体拮抗剂的氮杂双环衍生物
BRPI0413964B8 (pt) 2003-09-10 2021-05-25 Kyorin Seiyaku Kk ácido derivado do ácido carboxílico quinolona, sua composição e agente antibacterial
EP1670759A1 (en) * 2003-09-18 2006-06-21 Ranbaxy Laboratories Limited PROCESS FOR THE PREPARATION OF (1a, 5a, 6a)-6-AMINOME THYL-3-BENZYL-3-AZABICYCLO 3.1.0 HEXANE
TWI391378B (zh) * 2006-03-16 2013-04-01 Astellas Pharma Inc 喹啉酮衍生物或其製藥學上可被容許之鹽
PL2001862T3 (pl) 2006-03-28 2011-09-30 Warner Chilcott Co Llc Jabłczany oraz odmiany polimorficzne kwasu (3S,5S)-7-[3-amino-5-metylo-piperydynylo]-1-cyklopropylo-1,4-dihydro-8-metoksy-4-okso-3-chinolinokarboksylowego
US7456279B2 (en) 2006-03-28 2008-11-25 The Procter & Gamble Company Coupling process for preparing quinolone intermediates
US7902227B2 (en) * 2007-07-27 2011-03-08 Janssen Pharmaceutica Nv. C-7 isoxazolinyl quinolone / naphthyridine derivatives useful as antibacterial agents
JP2013542929A (ja) 2010-09-28 2013-11-28 パナセア バイオテック リミテッド 新規ビシクロ環化合物
US12421210B2 (en) * 2018-10-05 2025-09-23 New York University Fused bicyclic heterocycles as therapeutic agents
CN112442084B (zh) * 2020-12-03 2022-09-09 国药集团致君（深圳）制药有限公司 一种抗菌药中间体的制备方法
CN113307768B (zh) * 2021-04-29 2023-12-12 中国农业科学院兰州畜牧与兽药研究所 喹诺酮类衍生物及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0676400B2 (ja) * 1987-08-25 1994-09-28 大日本製薬株式会社 新規ピリドンカルボン酸誘導体、そのエステルおよびその塩
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
US4973091A (en) * 1989-09-20 1990-11-27 Truth Incorporated Sliding patio door dual point latch and lock

Also Published As

Publication number Publication date
NL980033I1 (nl) 1999-02-01
FI103879B (fi) 1999-10-15
CY1969A (en) 1997-09-05
WO1991002526A1 (en) 1991-03-07
NL980032I2 (nl) 1999-05-03
EG19251A (en) 1994-09-29
NZ234920A (en) 1992-06-25
PL166381B1 (pl) 1995-05-31
DK0413455T3 (da) 1995-08-14
CN1049501A (zh) 1991-02-27
PT94998B (pt) 1997-05-28
CA2023217A1 (en) 1991-02-17
NO920599D0 (no) 1992-02-14
JPH0386875A (ja) 1991-04-11
AU6104290A (en) 1991-02-21
GR3017072T3 (en) 1995-11-30
DD298399A5 (de) 1992-02-20
ES2074131T3 (es) 1995-09-01
CA2023217C (en) 1996-12-10
IE902950A1 (en) 1991-02-27
JPH072734B2 (ja) 1995-01-18
DE19875052I2 (de) 2009-05-28
CZ281127B6 (cs) 1996-06-12
CN1025192C (zh) 1994-06-29
IE66202B1 (en) 1995-12-13
AU623801B2 (en) 1992-05-21
IL95331A0 (en) 1991-06-30
DE69020262D1 (de) 1995-07-27
CZ402790A3 (en) 1996-04-17
CA2127561A1 (en) 1991-02-17
NL980032I1 (nl) 1999-02-01
LU90310I2 (fr) 1999-01-25
FI108228B (fi) 2001-12-14
PL286484A1 (en) 1991-05-20
BA98299A (bs) 2001-09-14
PT94998A (pt) 1991-04-18
ATE124040T1 (de) 1995-07-15
KR930004844B1 (ko) 1993-06-09
JPH0819099B2 (ja) 1996-02-28
FI103879B1 (fi) 1999-10-15
LU90311I2 (fr) 1999-01-25
JPH07149758A (ja) 1995-06-13
DE69020262T2 (de) 1995-10-26
KR910004572A (ko) 1991-03-28
EP0413455B1 (en) 1995-06-21
FI920632A0 (fi) 1992-02-14
EP0413455A2 (en) 1991-02-20
HK1000207A1 (en) 1998-02-06
NL980033I2 (nl) 1999-05-03
EP0413455A3 (en) 1991-10-09
NO300214B1 (no) 1997-04-28
ZA906450B (en) 1992-03-25
HU211681A9 (en) 1995-12-28
RU2049777C1 (ru) 1995-12-10
DE19875050I2 (de) 2009-05-28
FI964520A0 (fi) 1996-11-11
CY99010I2 (en) 2010-07-28
IL95331A (en) 1995-07-31
HU219403B (hu) 2001-04-28
NO920599L (no) 1992-04-14
FI964520L (fi) 1996-11-11
CA2127561C (en) 1998-07-28

Similar Documents

Publication Publication Date Title
ES2074131T4 (es) Acidos azabicicloquinolonacarboxilicos.
ATE115160T1 (de) Biologisch abbaubare polyphosphoester.
ES2056963T3 (es) Agentes antibacterianos.
FI900153L (fi) Administreringsanordningar baserade pao hydrogel.
BR9007858A (pt) Sistema de desinfeccao de lentes de contato
FI900697A0 (fi) Foerbaettrad jaemnhet hos mikrovaogsuppvaermning.
ES554142A0 (es) Procedimiento de obtencion de acidos quinolincarboxilicos con propiedades antibacteriales.
NO893376L (no) Nye antiarytmiske midler ii.
DE69012304D1 (de) Einrichtung zur Augenbehandlung.
DE69011033D1 (de) Alpha-Glukosidase-Inhibitoren.
FI884107A7 (fi) Bakteerinvastaisina aineina käytettäviä 4-okso-3-kinoliini-karboksyylihappoja ja niiden valmistus.
NO891027D0 (no) Kinolinderivater.
NO901257L (no) Kinolinderivater.
NO880587D0 (no) Bicykliske baa-laktam-karboksylsyrer.
DE69011254D1 (de) Vervielfältigungssystem.
DE69023097D1 (de) Mevalonsäure-Derivate.
DE59004025D1 (de) Verzweigte Copolymerisate.
DE3884300D1 (de) Magnetische Polymerzusammensetzungen.
DE3850907D1 (de) Magnetischer Näherungsschalter.
MY106854A (en) Azabicyclo quinolone carboxylic acids.
MD349B1 (ro) Stimulator ionic bipolar
FI914558A7 (fi) Bakteerinvastaisia 2-karbapeneemijohdannaisia
MX9203773A (es) Derivados de quinolina como antagonistas de leucotrieno d4.
DE59002596D1 (de) Sammelanschlussplatte.
FI895881A0 (fi) Regel.

Legal Events

Date Code Title Description
SPCF Request for supplementary protection certificate filed

Free format text: TROVAFLOXACINO (TROVAN)

Spc suppl protection certif: C9800036

Filing date: 19981130

SPCG Supplementary protection certificate granted

Free format text: TROVAFLOXACINO (TROVAN)

Spc suppl protection certif: C9800036

Filing date: 19981130

Expiry date: 20130703

Effective date: 20020514

SPCF Request for supplementary protection certificate filed

Free format text: ALATROFLOXACINO (TROVAN IV)

Spc suppl protection certif: C9800035

Filing date: 19981130

SPCG Supplementary protection certificate granted

Free format text: ALATROFLOXACINO (TROVAN IV)

Spc suppl protection certif: C9800035

Filing date: 19981130

Expiry date: 20130703

Effective date: 20030901